All

Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M)
30 October 2025

Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M)

• New investors Fidelity Management & Research Company, Janus Henderson Investors and Blackstone Multi-Asset Investing join Series C syndicate led by Venrock Healthcare...

Read the press release
Vertero Unveils New Strategic Direction Focused on Breaking Barriers in Neurodegenerative Diseases
22 October 2025

Vertero Unveils New Strategic Direction Focused on Breaking Barriers in Neurodegenerative Diseases

Axial Therapeutics today announced that it has rebranded as Vertero Therapeutics, a biotechnology company breaking barriers in neurodegenerative disease treatment. The new...

Read more
Enterome receives FDA Fast Track designation in follicular lymphoma for lead OncoMimics™ immunotherapy EO2463
16 October 2025

Enterome receives FDA Fast Track designation in follicular lymphoma for lead OncoMimics™ immunotherapy EO2463

Enterome, a clinical-stage company developing first-in-class OncoMimics™ immunotherapies to treat cancer, announces today that the U.S. Food and Drug Administration (FDA) has...

Read more
Sunrise Group: $29 Million Raised For Expanding Dreem Health
1 October 2025

Sunrise Group: $29 Million Raised For Expanding Dreem Health

Sunrise Group, known as a leader in sleep health technology, has announced a funding round of $29 million dedicated to expanding Dreem Health, its innovative digital sleep...

Read more
With a €860,000 investment, Seventure Partners joins Kapsera’s funding round, raising its Series A to €5 million.
22 September 2025

With a €860,000 investment, Seventure Partners joins Kapsera’s funding round, raising its Series A to €5 million.

Kapsera, a pioneer in sustainable microencapsulation for the agri-food industry, announces the entry of Seventure Partners into its capital as part of its Series A financing...

Read more
Algoan, a turnkey solution to meet new regulatory requirements
17 September 2025

Algoan, a turnkey solution to meet new regulatory requirements

Credit institutions, Buy Now, Pay Later providers and brokers, adopt our credit assessment and decision-making tools compliant with the new CCD2 directive.

Read more
YesWeHack completes first-ever acquisition with purchase of Sekost, French cybersecurity audit specialist
9 September 2025

YesWeHack completes first-ever acquisition with purchase of Sekost, French cybersecurity audit specialist

Paris, September 09, 2025 – YesWeHack, the global Bug Bounty and vulnerability management platform, has announced the acquisition of Sekost, an innovative player in the...

Read more
First Patient Dosed In Citryll’s Phase IIA Trial Evaluating CIT-013 In Rheumatoid Arthritis
2 September 2025

First Patient Dosed In Citryll’s Phase IIA Trial Evaluating CIT-013 In Rheumatoid Arthritis

Citryll, a biotech company pioneering a transformative approach to treating immune-mediated inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs), today...

Read more
SumUp Launches Terminal: An All-in-One POS for Growing Businesses
9 July 2025

SumUp Launches Terminal: An All-in-One POS for Growing Businesses

London, 9th July: Global fintech SumUp today launched SumUp Terminal, an all-in-one point of sale (POS) device that directly addresses the challenges faced by growing...

Read more
Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML
23 June 2025

Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML

60% (12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2).
EO2463 plus R2 was well tolerated in patients with...

Read more